The US Food and Drug Administration has posted to Twitter more details about an upcoming meeting of its outside advisory committee to discuss Pfizer and BioNTech's emergency use authorization application for a coronavirus vaccine candidate.
The Vaccines and Related Biological Products Advisory Committee will meet on Dec. 10.
"Starting Friday, the public will be able to submit comments to the public docket for this meeting, and those comments will be reviewed by the FDA," the agency tweeted on Wednesday. "Although the VRBPAC members provide advice to the agency, which may include advice on the safety and effectiveness data submitted in the EUA request, final decisions on whether to authorize the vaccine for emergency use are made by the FDA."
In a series of tweets, the FDA also noted that the committee is made up of scientific and public health experts and the committee meeting will be live-streamed on the agency's YouTube, Facebook and Twitter channels and from the FDA website.